Recent Finacing
Recent Raise
Prexton Therapeutics is a biopharmaceutical company developing mGluR4-targeting small molecules, including Foliglurax, for Parkinson’s disease and other CNS disorders using an integrated molecular, behavioral, and chemistry discovery platform.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
